Sameer A Parikh, MBBS

  • 1616 Citations
  • 24 Scopus h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sameer A Parikh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Leukemia, Myelomonocytic, Chronic Medicine & Life Sciences
Survival Medicine & Life Sciences
Lymphocytosis Medicine & Life Sciences
Fluorescence In Situ Hybridization Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies

Peterson, J. F., Baughn, L., Ketterling, R. P., Pitel, B. A., Smoley, S. A., Vasmatzis, G., Smadbeck, J., Greipp, P. T., Mangaonkar, A. A., Thompson, C. A., Parikh, S. A., Chen, D. & Viswanatha, D. S., Jan 1 2019, In : Blood Advances. 3, 8, p. 1298-1302 5 p.

Research output: Contribution to journalArticle

Open Access
Mantle-Cell Lymphoma
Cyclin D1
Fluorescence In Situ Hybridization
B-Cell Lymphoma
Cyclin D
Waldenstrom Macroglobulinemia
Clinical Trials
Confidence Intervals
Disease-Free Survival
Immunoglobulin M

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Open Access
Trisomy
B-Cell Chronic Lymphocytic Leukemia
Mutation
1 Citation (Scopus)

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Hampel, P. J., Ding, W. D., Call, T. G., Rabe, K. G., Kenderian, S., Witzig, T. E., Muchtar, E., Leis, J. F., Chanan Khan, A. A., Koehler, A. B., Fonder, A. L., Schwager, S. M., Slager, S. L., Shanafelt, T. D., Kay, N. E. & Parikh, S. A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease Progression
Clinical Trials
PCI 32765
Therapeutics